Rheumatoid Arthritis Clinical Trial Monitoring Brief

Austin Research Group
August 1, 2007
SKU: ARSG1552670
License type:
Table of Contents Search inside this report Related Reports
Austin Research Group’s Trial TRAX Clinical Intelligence Monitoring series provides detailed compilations and analysis of ongoing clinical studies within a specific therapeutic area or indication. Additionally, the Trial TRAX briefs contain synthesized background information on the profiled-disease; typically includes top-line information on:
  • Epidemiology
  • Patient Segmentation
  • Clinical endpoints
The Trial TRAX brief also contains analysis of the clinical landscape with assessments including:
  • % utilization of key clinical endpoints
  • Number of ongoing trials (by phase of development)
  • Key companies sponsoring clinical trials
The main body of the brief presents key data points from competitor clinical trials in a matrix format, enabling decision-makers the ability to quickly recall and analyze information on competitor studies. The brief’s reference-guide format is designed to provide decision makers with easy access to key intelligence on competitive clinical development programs. Primary data points include:
  • Study Drug
  • Mechanism of Action
  • Company-Sponsor
  • Phase of Development
  • Number of Patients
  • Study Design
  • Primary Endpoints
  • Study Start Date
Clients utilize the Trial TRAX briefing reports to:
  • Monitor clinical development programs of competitors
  • Quickly evaluate depth and breadth of competitive landscape
  • Easy-to-use reference guide for analyzing competitor clinical trials
  • Identify potential patient recruitment challenges
  • Benchmark competitor clinical trial designs



Additional Information

Companies mentioned in the report:
  • Amgen
  • Biogen
  • Pfizer
  • Eli Lilly
  • Genentech
  • Wyeth
Products mentioned in the report:
  • Enbrel
  • Ocrelizumab
 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Rheumatology/Arthritis Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!